Work

Vorinostat provides prolonged safety and clinical benefit to patients with advanced cutaneous t-cell lymphoma (CTCL)

Year: 2008

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2008.26.15_suppl.14588

Authors: E. A. Olsen, M. Duvic, D. Breneman, T. R. Pacheco, S. Parker, E. C. Vonderheid, J. L. Ricker, S. Rizvi, K. Boileau, L. J. Geskin

Language: English

Topic: Cutaneous lymphoproliferative disorders research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2248954893

Cites:

Cited by: 5

Related to: 10